0
Skip to Content
McKenzie Prillaman
Writing
About
Multimedia
Audio
Video
Research
Contact
McKenzie Prillaman
Writing
About
Multimedia
Audio
Video
Research
Contact
Writing
About
Folder: Multimedia
Back
Audio
Video
Research
Contact
Cedars-Sinai spearheads first national certification program for COE staff at cancer centers
The Cancer Letter McKenzie Prillaman 11/22/24 The Cancer Letter McKenzie Prillaman 11/22/24

Cedars-Sinai spearheads first national certification program for COE staff at cancer centers

The NCI Cancer Center Support Grant requires community outreach and engagement, but the design and implementation of COE programs, as well as staff training, are largely left to individual institutions.

Read More
Larry Einhorn, pioneer of platinum-based chemotherapy, discusses 50 years of cancer treatment innovation
The Cancer Letter McKenzie Prillaman 11/22/24 The Cancer Letter McKenzie Prillaman 11/22/24

Larry Einhorn, pioneer of platinum-based chemotherapy, discusses 50 years of cancer treatment innovation

When Larry Einhorn was a young physician in the early 1970s, actinomycin-D was the standard drug used to treat testicular cancer.

Read More
Ready or not, AI-based decision support tools are entering oncology clinics
The Cancer Letter McKenzie Prillaman 11/15/24 The Cancer Letter McKenzie Prillaman 11/15/24

Ready or not, AI-based decision support tools are entering oncology clinics

Regulators and health systems must adapt

Read More
Susan Ellenberg started out as a high school math teacher—then became a leading biostatistician
The Cancer Letter McKenzie Prillaman 10/25/24 The Cancer Letter McKenzie Prillaman 10/25/24

Susan Ellenberg started out as a high school math teacher—then became a leading biostatistician

A mathematical puzzle fascinated Susan Ellenberg as a child.

Read More
Is nivolumab superior to standard of care for classic Hodgkin lymphoma?
The Cancer Letter McKenzie Prillaman 10/18/24 The Cancer Letter McKenzie Prillaman 10/18/24

Is nivolumab superior to standard of care for classic Hodgkin lymphoma?

Phase III trial finds improved PFS, side effects with nivolumab+chemo

Read More
Latino oncology leaders discuss representation in clinical trials, translational research, and health care
The Cancer Letter McKenzie Prillaman 10/11/24 The Cancer Letter McKenzie Prillaman 10/11/24

Latino oncology leaders discuss representation in clinical trials, translational research, and health care

Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”

Read More
Tom Lynch reflects on discovery of EGFR mutations’ role in lung cancer
The Cancer Letter McKenzie Prillaman 10/4/24 The Cancer Letter McKenzie Prillaman 10/4/24

Tom Lynch reflects on discovery of EGFR mutations’ role in lung cancer

On Nov. 24, 2003, an article in The Boston Globe told the story of a patient’s remarkable response to gefitinib, a drug that had recently been approved by FDA.

Read More
AACR progress report highlights AI’s role in research and clinical care
The Cancer Letter McKenzie Prillaman 9/20/24 The Cancer Letter McKenzie Prillaman 9/20/24

AACR progress report highlights AI’s role in research and clinical care

Obstacles to progress include systemic disparities and dwindling appropriations

Read More
Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
The Cancer Letter McKenzie Prillaman 9/20/24 The Cancer Letter McKenzie Prillaman 9/20/24

Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine

Mace Rothenberg has stayed busy since stepping down as Pfizer’s chief medical officer in 2021 by pivoting to an ambitious endeavor in science communication: the Museum of Medicine and Biomedical Discovery.

Read More
Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
The Cancer Letter McKenzie Prillaman 9/13/24 The Cancer Letter McKenzie Prillaman 9/13/24

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows

Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies

Read More
Lung cancer couldn’t slow down physician and athlete Lawrence Phillips
The Cancer Letter McKenzie Prillaman 9/6/24 The Cancer Letter McKenzie Prillaman 9/6/24

Lung cancer couldn’t slow down physician and athlete Lawrence Phillips

Something odd turned up in one of Lawrence Phillips’s routine health screenings in 2008.

Read More
Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
The Cancer Letter McKenzie Prillaman 7/26/24 The Cancer Letter McKenzie Prillaman 7/26/24

Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025

What will happen to biomedical research and health care in the aftermath of the 2024 election? The differences in outcomes couldn’t be more stark.

Read More
Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa
The Cancer Letter McKenzie Prillaman 7/19/24 The Cancer Letter McKenzie Prillaman 7/19/24

Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa

The White House Cancer Moonshot is committing an additional $100 million to programs focused on reducing cancer burden in African countries.

Read More
“If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor
The Cancer Letter McKenzie Prillaman 7/12/24 The Cancer Letter McKenzie Prillaman 7/12/24

“If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor

Christy Erickson was seven years old when her mom lost a three-year battle with breast cancer.

Read More
High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
The Cancer Letter McKenzie Prillaman 6/28/24 The Cancer Letter McKenzie Prillaman 6/28/24

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward

NCI’s Youth Enjoy Science (YES) program also invests in student scientists

Read More
At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials
The Cancer Letter McKenzie Prillaman 6/28/24 The Cancer Letter McKenzie Prillaman 6/28/24

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Leaders of three health agencies presented new initiatives focused on patient-centered research, diversity in clinical trial enrollment, and innovation in clinical research.

Read More
Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC
The Cancer Letter McKenzie Prillaman 6/7/24 The Cancer Letter McKenzie Prillaman 6/7/24

Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC

Treatment with an indefinite course of osimertinib dramatically improves progression-free survival for patients with stage 3 non-small cell cancer, according to the results of the LAURA trial.

Read More
As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25
The Cancer Letter McKenzie Prillaman 5/24/24 The Cancer Letter McKenzie Prillaman 5/24/24

As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25

NCI Director Kimryn Rathmell joined the NIH director and four other institute directors in a May 23 Senate subcommittee hearing to craft the Labor-HHS spending bill for fiscal year 2025.

Read More
Older Posts

Writing About Audio Video Research Contact

Home page banner by Emily Moskal